Barely Significant
← all excerpts

HDAC Screening Identifies the HDAC Class I Inhibitor Romidepsin as a Promising Epigenetic Drug for Biliary Tract Cancer.

Cancers (Basel) · 2021 · PMC8345689 · PMID 34359763

Europe PMCDOI
1
hedged sentence
0.0500
closest p · 1.0× alpha
0.0500
boldest claim

The sentences

highly significantp < 0.05actually significant
Statistical results were considered significant (*) or highly significant (**) at p < 0.05 and p < 0.01, respectively. 3.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.